Company
IndiaPublic company, NYSE: WITWipro Limited (NYSE: WIT), Bengaluru, India – FDA Inspections
Inspection records and compliance data for Wipro Limited in Bengaluru. 1 FDA inspection on record, last inspected June 06, 2025. Publicly traded as NYSE: WIT.
Company Profile
This profile covers Wipro Limited based in Bengaluru, India.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 1
- Form 483s
- 0
- Warning letters
- 0
Inspected June 6, 2025.
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| June 6, 2025 | NAI | Human Drugs · Drug Quality Assurance | 1275200 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Biological E. Limited
Analys Lab Private Limited
Sun Pharmaceutical Industries Limited
Nalanda Research Laboratories
INTERVEIN RESEARCH LABS PRIVATE LIMITED
PAR Formulations Private Limited
Pharmaffiliates Analytics & Synthetics Pvt., Ltd.
RiconPharma India Private Ltd.
Indoco Remedies Limited
Fusion Scientific Laboratories Pvt. Ltd
Company Information
Name
Wipro Limited
Stock ticker
WIT
Exchange
NYSE
Share price
$2.16
Market cap
$21.4B
Price as of
November 6, 2026
FEI Number
3011665699
Address
Sarjapur Road, Bengaluru, India
Country
India
ID: 0fd16641-8e77-4285-b734-65cabc92404d